RaySearch Laboratories AB (publ) (STO:RAY.B)
Sweden · Delayed Price · Currency is SEK 175.30
-2.60 (-1.46%)
Jul 21, 2026, 1:44 PM CET
RaySearch Laboratories AB Market Cap
RaySearch Laboratories AB has a market cap or net worth of 6.1 billion as of July 21, 2026. Its market cap has decreased by -50.65% in one year.
Market Cap
6.10B
Enterprise Value
6.04B
Revenue
1.30B
Ranking
n/a
PE Ratio
27.22
Stock Price
175.30
ChartMarket Cap Chart
Since October 30, 2003, RaySearch Laboratories AB's market cap has increased from 189.23M to 6.10B, an increase of 3,122.96%. That is a compound annual growth rate of 16.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 6.10B | -21.97% |
| Dec 30, 2025 | 7.82B | 5.56% |
| Dec 30, 2024 | 7.41B | 139.20% |
| Dec 29, 2023 | 3.10B | 32.79% |
| Dec 30, 2022 | 2.33B | 20.35% |
| Dec 30, 2021 | 1.94B | -31.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 159.71B |
| Getinge AB | 63.33B |
| Sectra AB | 53.02B |
| Camurus AB | 37.40B |
| Apotea AB | 8.27B |
| MedCap AB | 7.72B |
| Synsam AB | 7.67B |
| Xvivo Perfusion AB | 7.52B |